ADVB — ADVANCED BIOMED Cashflow Statement
0.000.00%
Last trade - 00:00HealthcareMicro Cap
Annual cashflow statement for ADVANCED BIOMED, fiscal year end - June 30th, USD millions except per share, conversion factor applied.
2021 June 30th | 2022 June 30th | |
|---|---|---|
| Period Length: | 12 M | 12 M |
| Source: | PROSPECTUS/A | PROSPECTUS/A |
| Standards: | USG | USG |
| Status: | Final | Final |
| Net Income/Starting Line | -1.84 | -4.03 |
| Depreciation | ||
| Non-Cash Items | -0 | 1.66 |
| Unusual Items | ||
| Other Non-Cash Items | ||
| Changes in Working Capital | 1.31 | 1.5 |
| Change in Prepaid Expenses | ||
| Change in Accrued Expenses | ||
| Change in Payable / Accrued Expenses | ||
| Other Operating Cash Flow | ||
| Cash from Operating Activities | -0.474 | -0.741 |
| Capital Expenditures | -0.025 | -1.31 |
| Purchase of Fixed Assets | ||
| Purchase / Acquisition of Intangibles | ||
| Other Investing Cash Flow Items | 0 | 0.228 |
| Sale of Business | ||
| Sale of Fixed Assets | ||
| Cash from Investing Activities | -0.025 | -1.08 |
| Net Issuance / Retirement of Stock | ||
| Cash from Financing Activities | 0.697 | 6.1 |
| Foreign Exchange Effects | ||
| Beginning Cash Balance | ||
| Ending Cash Balance | ||
| Net Change in Cash | 0 | 4.72 |